(MedPage Today) — Hurdles to receive GLP-1 receptor agonists rose sharply in the last several years for Medicare Part D beneficiaries, a national study showed.
Nearly all plans instituted prior authorization from 2020 to 2025, and many started…
Source link : https://www.medpagetoday.com/endocrinology/diabetes/117619
Author :
Publish date : 2025-09-24 15:00:00
Copyright for syndicated content belongs to the linked Source.
